|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.5 INR | +6.26% |
|
+11.15% | -6.75% |
Sandu Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 653.49 million. Revenue was INR 656.76 million.
Net income was INR 15.21 million. Basic earnings per share from continuing operations was INR 1.62. Diluted earnings per share from continuing operations was INR 1.62.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.75% | 7.35M | |
| +27.19% | 5.56B | |
| -33.59% | 3.52B | |
| -2.97% | 3.01B | |
| -24.21% | 2.65B | |
| -10.11% | 2.3B | |
| +43.66% | 1.91B | |
| +46.15% | 1.5B | |
| -13.92% | 1.41B | |
| +41.90% | 1.37B |
SANDU PHARMACEUTICALS LIMITED 
